Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 499.88 billion as of May 13, 2025. Its market cap has decreased by -37.39% in one year.

Market Cap

499.88B

Enterprise Value

522.82B

Revenue

15.05B

Ranking

n/a

PE Ratio

n/a

Stock Price

10,410.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 499.88B, an increase of 952.51%. That is a compound annual growth rate of 11.18%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	499.88B	-11.03%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1,038.98B	-4.44%
Dec 29, 2022	1,087.24B	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	1,048.68B	115.45%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	70.53T
Celltrion	32.90T
ALTEOGEN	18.55T
Yuhan	8,074.07B
HLB Co., Ltd.	7,489.60B
SK Biopharmaceuticals	7,204.82B
PharmaResearch	4,135.08B
Peptron	3,983.85B

Market Cap Rankings